Ruxolitinib Cream for Childhood Vitiligo
Part of Skin clinical trials.
This study tests whether a cream called ruxolitinib can help restore skin color in children ages 2–11 with vitiligo, a condition causing white patches on the skin. The cream works by reducing inflammation that stops the body from making skin pigment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is between 2 and 11 years old
- Your child has non-segmental vitiligo (white patches that may appear in multiple areas), not segmental vitiligo (patches only on one side of the body)
- The white patches cover at least 0.1% of your child's skin but no more than 10% total
- Your child has not used any other treatments specifically for depigmentation or vitiligo
- Your child has never failed treatment with JAK inhibitor drugs (a type of anti-inflammatory medicine)
- You and your child can attend all scheduled follow-up visits
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a cream called ruxolitinib for adults with vitiligo on the face and neck that has not responded well to another cream (tacrolimus). The goal is to see if this cream can help bring back skin color.
This study tests how well a cream called ruxolitinib works for vitiligo in real-world conditions. It looks at what factors might make the treatment more or less effective.
This trial tests whether adding a type of light therapy (narrow-band UVB) to a daily pill called ritlecitinib works better than the pill alone for treating vitiligo. It may help if you have non-segmental vitiligo covering a moderate amount of skin.
This trial compares two medicines—oral tacrolimus and dexamethasone micro-pulse therapy—in children aged 4 to 12 whose vitiligo is spreading quickly. The goal is to see which treatment works better to stop the spread and help color return to the skin.
This study tests whether a cream called ruxolitinib can help children ages 6 to 11 with nonsegmental vitiligo. It aims to see if the cream safely restores color to white patches on the face and body.
This study tests a cream called ruxolitinib for children with nonsegmental vitiligo. It aims to see if the cream can safely help restore skin color in affected areas.
Hear when a new Vitiligo trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.